Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 7 most recent Form 4 transactions.
| Aclaris Therapeutics, Inc. |
| MEXER◆ |
| 11,580 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 5 | ACRS | Aclaris Therapeutics, Inc. | MEXER | 11,580 | — | — | +66.9% | Open the original filing on SEC.gov |
| Jun 4 | ACRS | Aclaris Therapeutics, Inc. | AGRANT◆ | 10,987 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | ACRS | Aclaris Therapeutics, Inc. | AGRANT◆ | 42,350 | — | — | — | Open the original filing on SEC.gov |
| May 29 | BCRX | Biocryst Pharmaceuticals… | AGRANT | 1,122 | $8.91 | $10K | +1.2% | Open the original filing on SEC.gov |